InsidersTradesSigma
EQL Pharma AB Stock: price and management transactions · Finland · FIN-FSA
Follow the EQL Pharma AB share price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, EQL Pharma AB has logged 8 reports. Market capitalisation: €720.5m. The latest transaction was disclosed on 27 March 2026 (Sale). Among the most active insiders: Axel Schörling. All data is free.
8
Insider Decl.
0
Thresholds
€100,159
3 ops.
Buy Volume
€118,679
2 ops.
Sell Volume
31Σ signal
Fundamental score
Ranked 21,178 of 25,899 companies
29.4
score / 100
Value27
Quality32
FCF yld-5.5%
Earn yld1.8%
EV/EBITDA24.5x
ROE-1.1%
Gross mgn38%
Net mgn2.9%
Debt/EBITDA10.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 27 March 2026
Declarations8 total
24,066 shares@ €4.71440.015% mcap54.7% of flowAktieFI:A003X402-1
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
1,000 shares@ €6.14510.0008% mcap100.0% of flowAktieFI:A003S651-1
Ideal exit: 20 Jun 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
667 shares@ €7.83030.0007% mcap100.0% of flowAktieFI:A003S329-1
289,155 shares0AktieFI:A003S161-1
38,370 shares0AktieFI:A003S141-2
345,642 shares0AktieFI:A003S140-1
100,000 shares@ €0.66060.0086% mcap31.8% of flowTeckningsoptionFI:A003R671-1
Ideal exit: 20 May 2026 (T+270)
3,650 shares@ €7.65830.0036% mcap13.5% of flowAktieFI:A003O464-1
Ideal exit: 10 Feb 2026 (T+270)
8 of 8 declarations